These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25576367)

  • 1. Comorbid substance use disorders in schizophrenia: a latent class approach.
    Kerner B
    Psychiatry Res; 2015 Feb; 225(3):395-401. PubMed ID: 25576367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dual diagnosis psychosis and substance use disorders in adolescents--part 1].
    Meister K; Burlon M; Rietschel L; Gouzoulis-Mayfrank E; Bock T; Lambert M
    Fortschr Neurol Psychiatr; 2010 Feb; 78(2):81-9. PubMed ID: 20146152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the pattern of substance abuse after the onset of psychosis.
    Kaiser R; Löhrer F; Morgan V; Hambrecht M
    Aust N Z J Psychiatry; 2005 Jun; 39(6):467-72. PubMed ID: 15943648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhalant abusers and psychiatric symptoms].
    Okudaira K; Yabana T; Takahashi H; Iizuka H; Nakajima K; Saito A
    Seishin Shinkeigaku Zasshi; 1996; 98(4):203-12. PubMed ID: 8710994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients.
    Havassy BE; Arns PG
    Psychiatr Serv; 1998 Jul; 49(7):935-40. PubMed ID: 9661229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant relationship between lifetime alcohol use disorders and suicide attempts in an Australian schizophrenia sample.
    McLean D; Gladman B; Mowry B
    Aust N Z J Psychiatry; 2012 Feb; 46(2):132-40. PubMed ID: 22311529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is there a temporal correlation between substance abuse and psychosis in adolescents?].
    Holtmann M; Becker K; Hartmann M; Schmidt MH
    Z Kinder Jugendpsychiatr Psychother; 2002 May; 30(2):97-103. PubMed ID: 12053879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychotic disorders and drug abuse in adolescents].
    Fleischhaker C; Priemer K; Schulz E; Remschmidt H
    Z Kinder Jugendpsychiatr Psychother; 2002 May; 30(2):87-95. PubMed ID: 12053878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology, etiology and treatment of patients with psychosis and co-morbid substance use disorder].
    Moggi F
    Ther Umsch; 2018 Jun; 75(1):37-43. PubMed ID: 29909760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbid substance use and age at onset of schizophrenia.
    Barnes TR; Mutsatsa SH; Hutton SB; Watt HC; Joyce EM
    Br J Psychiatry; 2006 Mar; 188():237-42. PubMed ID: 16507965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
    Green AI
    J Clin Psychiatry; 2005; 66 Suppl 6():21-6. PubMed ID: 16107180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlates of subsyndromal depression in African American individuals with psychosis: The relationship with positive symptoms and comorbid substance dependence.
    Knowles EEM; Mathias SR; Pearlson GD; Barrett J; Mollon J; Denbow D; Aberzik K; Zatony M; Glahn DC
    Schizophr Res; 2019 Apr; 206():333-346. PubMed ID: 30482645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance use disorder comorbidity with schizophrenia in families of Mexican and Central American ancestry.
    Jiménez-Castro L; Hare E; Medina R; Raventos H; Nicolini H; Mendoza R; Ontiveros A; Jerez A; Muñoz R; Dassori A; Escamilla M
    Schizophr Res; 2010 Jul; 120(1-3):87-94. PubMed ID: 20303714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use in a large sample of patients with schizophrenia or related disorders and co-morbid obsessive-compulsive symptoms.
    Dekker N; Swets M;
    Aust N Z J Psychiatry; 2013 Sep; 47(9):868-74. PubMed ID: 23723291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of Schizophrenia or Psychosis-Related Symptoms in Adults Undergoing Substance Abuse Evaluation.
    Trudeau KJ; Burtner J; Villapiano AJ; Jones M; Butler SF; Joshi K
    J Nerv Ment Dis; 2018 Jul; 206(7):528-536. PubMed ID: 29905667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.
    Compton MT; Weiss PS; West JC; Kaslow NJ
    Soc Psychiatry Psychiatr Epidemiol; 2005 Dec; 40(12):939-46. PubMed ID: 16247563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of psychosis remission in psychotic disorders that co-occur with substance use.
    Caton CL; Hasin DS; Shrout PE; Drake RE; Dominguez B; Samet S; Schanzer B
    Schizophr Bull; 2006 Oct; 32(4):618-25. PubMed ID: 16873441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.